Texas Gov. Greg Abbott, continuing a three-day series of border security-related actions, issued five executive orders Wednesday directing state agencies to assist President Donald Trump’s immigration ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

Available in Obsidian Black and Snow White, the HUAWEI FreeBuds Pro 4 is coated with six layers of protective lacquer for a glossy finish and marked with the iconic golden HUAWEI SOUND logo.

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of $136.00. The company’s shares closed yesterday at ...

Abbott Laboratories (NYSE:ABT) reported its Q3 2024 earnings, meeting EPS expectations while slightly missing revenue forecasts. The company posted an EPS of $1.34, aligning with analysts' predictions ...

Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks expected to post impressive earnings this week. The earnings season is in full flow ...

The S&P 500 briefly hit 6,100 points on Wednesday, reaching a fresh all-time high as Wall Street embraced a powerful mix of strong corporate earnings and President Donald Trump's bold $500 billion ...

Abbott Laboratories expects first quarter 2025 adjusted EPS of $1.05-$1.09 versus consensus of $1.11. Price Action: ABT stock is up 0.72% at $117.64 at the last check Wednesday.

On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...

(RTTNews) - Abbott Laboratories (ABT) revealed a profit for its fourth quarter that increased from last year in line with the Street estimates. The company's bottom line totaled $9.229 billion ...

Jan 22 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand ...